K Number
K982800
Device Name
ECTON LYNX ULTRASOUND SYSTEM
Manufacturer
Date Cleared
1998-09-22

(43 days)

Product Code
Regulation Number
892.1560
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Diagnostic Ultrasound imaging or fluid flow analysis of the human body as follows: Fetal, Abdominal, Intraoperative-Cardiac, Pediatric, Neonatal Cephalic, Cardiac (Adult), Cardiac (Pediatric), Transesophageal, Peripheral Vascular. The Ecton Lynx is not intended for ophthalmic, intraoperative neuralgic, or adult cephalic imaging. The system may be used with or without legally marketed ultrasound contrast agents. The system makes no claims regarding the use of ultrasonic contrast agents but provides harmonic imaging capability, receiving echoes at a multiple of the transmit signal and providing electrocardiographic gating that may be used in conjunction with contrast agents.
Device Description
The Ecton Lynx Ultrasound System is a general purpose and cardiac diagnostic ultrasound system. It is a highly portable digital system. Its function is to transmit and acquire ultrasound image data and display it on a monitor. The system operates in 2D, M-Mode, Color Flow Doppler, Doppler Tissue Imaging, and Continuous Wave Doppler modes. The Lynx provides the operator with the ability to perform measurements and calculations on images using established clinical formulae. The Lynx complies with the Track 3 Output Display Standard, providing an automatic display of Mechanical Index and Thermal Index. The Ecton Lynx is designed to operate linear and linear phased array transducers (probes). Four probes are included in the current submission: a 2.5MHz external probe, a 5.0MHz external probe, a 5.0MHz biplane transesophageal probe, and a 5.0MHz monoplane transesophageal probe. The transesophageal probes contain a temperature sensing device that is used to limit the surface temperature to 43 degrees C. The Ecton Lynx includes a stress echocardiography software package that utilizes conventional techniques to capture and format images for stress echocardiography studies. The system provides digital output of images in conformance with the DICOM standard. The Lynx does not utilize lossy compression techniques in image storage or transmission.
More Information

Not Found

No
The document describes a standard diagnostic ultrasound system with various imaging modes and measurement capabilities. There is no mention of AI, ML, deep learning, or any related technologies in the device description, intended use, or performance studies sections. The image processing mentioned is likely conventional signal processing for ultrasound image formation.

No
The device is described as a "Diagnostic Ultrasound imaging" system, and its intended use is for "Diagnostic Ultrasound imaging or fluid flow analysis." Diagnostic devices are used to identify or determine a disease or condition, not to treat it.

Yes

Explanation: The 'Intended Use / Indications for Use' explicitly states "Diagnostic Ultrasound imaging or fluid flow analysis of the human body". Furthermore, the 'Device Description' refers to "The Ecton Lynx Ultrasound System is a general purpose and cardiac diagnostic ultrasound system".

No

The device description explicitly mentions hardware components such as transducers (probes) and a temperature sensing device within the transesophageal probes. It is described as a "system" that transmits and acquires ultrasound data, which inherently involves hardware.

Based on the provided information, the Ecton Lynx Ultrasound System is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states "Diagnostic Ultrasound imaging or fluid flow analysis of the human body". This describes a device that interacts directly with the patient's body to produce images or analyze physiological processes in vivo.
  • Device Description: The description details how the system transmits and acquires ultrasound data from the body and displays it. It mentions different imaging modes and the ability to perform measurements on these images. This is consistent with an in vivo diagnostic imaging device.
  • Lack of IVD Characteristics: An IVD device is typically used to examine specimens (like blood, urine, tissue) outside the body (in vitro) to provide information about a person's health. The Ecton Lynx does not mention any interaction with biological specimens or analysis performed outside the body.

Therefore, the Ecton Lynx is an in vivo diagnostic imaging device, not an IVD.

N/A

Intended Use / Indications for Use

The Ecton Lynx is intended for adult and pediatric cardiac, intraoperative cardiac, peripheral vascular, abdominal, fetal, pediatric and neonatal cephalic imaging. The Lynx is not intended for ophthalmic, intraoperative neuralgic, or adult cephalic imaging. The system may be used with or without legally marketed ultrasound contrast agents. The system makes no claims regarding the use of ultrasonic contrast agents but provides harmonic imaging capability, receiving echoes at a multiple of the transmit signal and providing electrocardiographic gating that may be used in conjunction with contrast agents. Indications for use include:

  • Adult and pediatric cardiac studies usinq external probes.
  • Intraoperative adult and pediatric (size permitting) cardiac studies using a transesophageal probe.
  • Intraoperative adult and cardiac studies using a . sheathed "external" probe.
  • Adult and pediatric (size permitting) cardiac studies using a transesophageal probe.
  • Abdominal studies.
  • Pediatric studies to detect abnormalities in organs, superficial or bony structures.
  • Neonatal cephalic studies.
  • Peripheral vascular studies including cerebrovasculature and extremeties.
  • Fetal studies.

Product codes (comma separated list FDA assigned to the subject device)

90IYN, 90IYO, 90ITX

Device Description

The Ecton Lynx Ultrasound System is a qeneral purpose and cardiac diagnostic ultrasound system. It is a highly portable digital system. Its function is to transmit and acquire ultrasound image data and display it on a monitor. The system operates in 2D, M-Mode, Color Flow Doppler, Doppler Tissue Imaging, and Continuous Wave Doppler modes. The Lynx provides the operator with the ability to perform measurements and calculations on images using established clinical formulae. The Lynx complies with the Track 3 Output Display Standard, providing an automatic display of Mechanical Index and Thermal Index.

The Ecton Lynx is designed to operate linear and linear phased array transducers (probes). Four probes are included in the current submission: a 2.5MHz external probe, a 5.0MHz external probe, a 5.0MHz biplane transesophageal probe, and a 5.0MHz monoplane transesophageal probe. The transesophaqeal probes contain a temperature sensing device that is used to limit the surface temperature to 43 degrees C.

The Ecton Lynx includes a stress echocardiography software package that utilizes conventional techniques to capture and format images for stress echocardiography studies. The system provides digital output of images in conformance with the DICOM standard. The Lynx does not utilize lossy compression techniques in image storage or transmission.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Ultrasound

Anatomical Site

Cardiac (Adult and Pediatric), Intraoperative Cardiac, Peripheral Vascular, Abdominal, Fetal, Pediatric, Neonatal Cephalic. Does not include Ophthalmic, Intraoperative Neuralgic, or Adult Cephalic.

Indicated Patient Age Range

Adult and Pediatric, including Neonatal

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K934041, K935009, K891689, K97376, K964309

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.1560 Ultrasonic pulsed echo imaging system.

(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

0

K'982802

SEP 2 2 1998

Ecton

Suite 100 110 West Butler Avenue Ambler, Pennsylvania 19002 215 283-1800 Fax 215 283-1809

4.2

510(k) Summary of Safety and Effectiveness 21CFR 807.92

  1. Submitter's Name/Address/Phone/Contact Person:

Christopher B. Knell Director of Engineering Ecton, Inc. Suite 100 110 West Butler Avenue Ambler, Pennsylvania 19002 215 283 1800π 215 283 1809 (fax) c.knell@ieee.com (email)

Date Summary Was Prepared: June 6, 1998

Name of the device, including the trade or 2) proprietary name if applicable, the common or usual name, and the classification name, if known:

Common/Usual Name:

Diagnostic Ultrasound System

Proprietary Name:

Ecton Lynx Ultrasound System

Classification Names:

The FDA has classified Ultrasound Imaging Systems as Class II in 21 CFR:

FR #/ Product Code

892.1550/90IYN Ultrasonic Pulsed Doppler Imaging System 892.1560/90IYO Ultrasonic Pulsed Echo Imaging System 892.1570/ 90ITX Diagnostic Ultrasound Transducer

1

3) Predicate Devices:

In this 510(k) submission, the legally marketed devices to which we claim substantial equivalence are:

ManufacturerProductK Number
Hewlett Packard Co.Sonos 2500 Ultrasound
SystemK934041
ATL, Inc.HDI 3000 Ultrasound
SystemK935009
KontronMipron Image Processing
SystemK891689
Acuson Corp.Sequoia: Harmonic
Imaging with ContrastK97376
Hewlett Packard Co.Sonos 2500:
Harmonic ImagingK964309

Device Description 4)

The Ecton Lynx Ultrasound System is a qeneral purpose and cardiac diagnostic ultrasound system. It is a highly portable digital system. Its function is to transmit and acquire ultrasound image data and display it on a monitor. The system operates in 2D, M-Mode, Color Flow Doppler, Doppler Tissue Imaging, and Continuous Wave Doppler modes. The Lynx provides the operator with the ability to perform measurements and calculations on images using established clinical formulae. The Lynx complies with the Track 3 Output Display Standard, providing an automatic display of Mechanical Index and Thermal Index.

The Ecton Lynx is designed to operate linear and linear phased array transducers (probes). Four probes are included in the current submission: a 2.5MHz external probe, a 5.0MHz external probe, a 5.0MHz biplane transesophageal probe, and a 5.0MHz monoplane transesophageal probe. The transesophaqeal probes contain a temperature sensing device that is used to limit the surface temperature to 43 degrees C.

The Ecton Lynx includes a stress echocardiography software package that utilizes conventional techniques to capture and format images for stress echocardiography

4.2 Summary of Safety and Effectiveness

2

studies. The system provides digital output of images in conformance with the DICOM standard. The Lynx does not utilize lossy compression techniques in image storage or transmission.

The Ecton Lynx has been designed to meet or exceed the following safety standards:

IEC601-1: International Electrotechnical Commission, Medical Electrical Equipment

C22.2 No. 601.1: Canadian Standards Association, Medical Electrical Equipment

IEC 601-1-2 International Electrotechnical Commission, Collateral Standard: Electromagnetic Compatibility

5) Indications for Use / Intended Use

The Ecton Lynx is intended for adult and pediatric cardiac, intraoperative cardiac, peripheral vascular, abdominal, fetal, pediatric and neonatal cephalic imaging. The Lynx is not intended for ophthalmic, intraoperative neuralgic, or adult cephalic imaging. The system may be used with or without legally marketed ultrasound contrast agents. The system makes no claims regarding the use of ultrasonic contrast agents but provides harmonic imaging capability, receiving echoes at a multiple of the transmit signal and providing electrocardiographic gating that may be used in conjunction with contrast agents. Indications for use include:

· Adult and pediatric cardiac studies usinq external probes.

· Intraoperative adult and pediatric (size permitting) cardiac studies using a transesophageal probe.

Intraoperative adult and cardiac studies using a . sheathed "external" probe.

. Adult and pediatric (size permitting) cardiac studies using a transesophageal probe.

· Abdominal studies.

· Pediatric studies to detect abnormalities in organs, superficial or bony structures.

3

· Neonatal cephalic studies.

Peripheral vascular studies including cerebrovasculature and extremeties.

Fetal studies.

6) Technological Characteristics

The Ecton Lynx operates in a manner that is identical to the predicate devices for each scanning mode: piezoelectric material in the transducer is used as an ultrasound generator to transmit sound waves into the body. Reflected sound waves are received by the transducer and converted into electrical signals that are processed and displayed as 2D (B-Mode) or M-Mode images. Doppler shift techniques are used to process signals and display them as 2D color flow velocity maps Doppler Tissue Imaging, or continuous wave spectral Doppler.

The Lynx conforms to the Standard for Real-Time Display of Thermal and Mechanical Acoustic Indices on Diagnostic Ultrasound Equipment (AIUM/NEMA 1996) for the on-screen display of mechanical and thermal indices. This feature provides the user with information on potential thermal and cavitation bioeffect mechanisms. A user education program provides information instructing users on machine settings and scanning techniques that allow for examinations to be conducted in accordance with the ALARA (as low as reasonably achievable) principle.

The acoustic output limits of the Lynx are the same as predicate Track 3 devices:

Acoustic Output Limits*

ISPTA720 mW/cm2(Maximum)
TIS/TIB/TIC0.1 - 4.0(Range)
Mechanical Index1.9(Maximum)
ISPPA0-700 W/cm²(Range)

*the Lynx is not intended for ophthalmic uses.

7 ) Potential Adverse Affects

This device has no known adverse affects on human health when used in the prescribed manner for the intended uses.

4

Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular in shape, with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. In the center of the circle is an abstract symbol that resembles an eagle or other bird in flight. The symbol is composed of three curved lines that suggest the wings and body of the bird.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

SEP 2 2 1998

Ecton, Inc. c/o Robert Mosenkis Citech 5200 Butler Pike Plymouth Meeting, PA 19462

Re: K982800 Ecton Lynx Ultrasound System Regulatory Class: II/21 CFR 892.1560 Product Code: 90 IYO Dated: September 10, 1998 Received: September 11, 1998

Dear Mr. Mosenkis:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

This determination of substantial equivalence applies to the following transducers intended for use with the Ecton Lynx Ultrasound System, as described in your premarket notification:

Transducer Model Number

  • 2.7 MHz External Transducer
  • 5.0 MHz External Transducer
  • 5.0 MHz Biplane Transesophageal Transducer
  • 5.0 MHz Monoplane Transesophageal Transducer

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval) it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (OS) for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic OS inspections, the FDA will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification does not affect any obligation you may have under sections 531 and 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

5

Page 2 - Robert Mosenkis

This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.

The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:

Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850

This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

If you have any questions regarding the content of this letter, please contact Robert A. Phillips, Ph.D. at (301) 594-1212.

Sincerely yours,

Elaine A. Szymoniak

Lillian Yin, Ph.D.

Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosures

6

4.2 / / 4.3

Indications for Use Form

Ecton Lynx Ultrasound System

Diagnostic Ultrasound imaging or fluid flow Intended Use: analysis of the human body as follows:

System Indications

| Clinical Application | B | M | CWD | Color
Doppler | Amplitude
Doppler
(Doppler
Tissue
Imaging) | Other
(specify)
Harmonic
Imaging |
|------------------------|---|---|-----|------------------|--------------------------------------------------------|-------------------------------------------|
| Fetal | • | • | • | • | • | • |
| Abdominal | • | • | • | • | • | • |
| Intraoperative-Cardiac | • | • | • | • | • | • |
| Pediatric | • | • | • | • | • | • |
| Neonatal Cephalic | • | • | • | • | • | • |
| Cardiac (Adult) | • | • | • | • | • | • |
| Cardiac (Pediatric) | • | • | • | • | • | • |
| Transesophageal | • | • | • | • | • | • |
| Peripheral Vascular | • | • | • | • | • | • |

Additional Comment: The Ecton Lynx does not provide Combined Modes (where more than one scanning mode is active simultaneously.)

New Submission: All Indications New

4.3 p 1

Prescription Use (Per 21 CFR 801.109)

Concurrence of CDRH, Office of Device Evaluation (ODE)

David G. Seaymore

(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological D

510(k) Number K982800

4.2/4.3 Indications

7

4.2 / / / 4.3

Indications for Use Form

Ecton Lynx Ultrasound System

Diagnostic Ultrasound imaging or fluid flow Intended Use: analysis of the human body as follows:

2.7 MHz External Transducer

| Clinical Application | B | M | CWD | Color
Doppler | Amplitude
Doppler
(Doppler
Tissue
Imaging) | Other
(specify)
Harmonic
Imaging |
|------------------------|---|---|-----|------------------|--------------------------------------------------------|-------------------------------------------|
| Fetal | • | • | • | • | • | • |
| Abdominal | • | • | • | • | • | • |
| Intraoperative-Cardiac | • | • | • | • | • | • |
| Pediatric | • | • | • | • | • | • |
| Cardiac (Adult) | • | • | • | • | • | • |
| Cardiac (Pediatric) | • | • | • | • | • | • |
| Peripheral Vascular | • | • | • | • | • | • |

Additional Comment: The Ecton Lynx does not provide Combined Modes (where more than one scanning mode is active simultaneously.)

New Submission: All Indications New

4.3 p 2

Prescription Use (Per 21 CFR 801.109)

Concurrence of CDRH, Office of Device Evaluation (ODE)

David U. Segner
(Division Sign-Off)

(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Dev 510(k) Number

8

4.2 / / / 4.3

Indications for Use Form

Ecton Lynx Ultrasound System

Intended Use: Diagnostic Ultrasound imaging or fluid flow analysis of the human body as follows:

5.0 MBz External Transducer

| Clinical Application | B | M | CWD | Color
Doppler | Amplitude
Doppler
(Doppler
Tissue
Imaging) | Other
(specify)
Harmonic
Imaging |
|------------------------|---|---|-----|------------------|--------------------------------------------------------|-------------------------------------------|
| Fetal | ● | ● | ● | ● | ● | ● |
| Abdominal | ● | ● | ● | ● | ● | ● |
| Intraoperative-Cardiac | ● | ● | ● | ● | ● | ● |
| Pediatric | ● | ● | ● | ● | ● | ● |
| Neonatal Cephalic | ● | ● | ● | ● | ● | ● |
| Cardiac (Adult) | ● | ● | ● | ● | ● | ● |
| Cardiac (Pediatric) | ● | ● | ● | ● | ● | ● |
| Transesophageal | ● | ● | ● | ● | ● | ● |
| Peripheral Vascular | ● | ● | ● | ● | ● | ● |

Additional Comment: The Ecton Lynx does not provide Combined Modes (where more than one scanning mode is active simultaneously.)

New Submission: All Indications New

4.3 p 3

Prescription Use (Per 21 CFR 801.109)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Daniel A. Szymer

(Division Sign-Off) Division of Reproductive, Abdominal, ENT, and Radiological Devi

510(k) Number K942800

4.2/4.3 Indications

9

4.2 / / 4.3

Indications for Use Form

Ecton Lynx Ultrasound System

Intended Use: Diagnostic Ultrasound imaging or fluid flow analysis of the human body as follows:

5.0 MHz Biplane Transesophageal Transducer

| Clinical Application | B | M | CWD | Color
Doppler | Amplitude
Doppler
(Doppler
Tissue
Imaging) | Other
(specify)
Harmonic
Imaging |
|------------------------|---|---|-----|------------------|--------------------------------------------------------|-------------------------------------------|
| | | | | | | |
| Intraoperative-Cardiac | ● | ● | ● | ● | ● | ● |
| Cardiac (Adult) | ● | ● | ● | ● | ● | ● |
| Cardiac (Pediatric) | ● | ● | ● | ● | ● | ● |
| Transesophageal | ● | ● | ● | ● | ● | ● |

Additional Comments: Pediatric studies are dependent upon patient size. The Ecton Lynx does not provide Combined Modes (where more than one scanning mode is active simultaneously. )

New Submission: All Indications New

4.3 p 4

Prescription Use (Per 21 CFR 801.109)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Daniel A. Segerson

(Division Sign-Off) (Division of Reproductive, Abdominal, ENT, and Radiological Devic 510(k) Number

10

4.2 / / 4.3

Indications for Use Form

Ecton Lynx Ultrasound System

Intended Use: Diagnostic Ultrasound imaging or fluid flow analysis of the human body as follows:

5.0 MBz Monoplane Transesophageal Transducer

| Clinical Application | B | M | CWD | Color
Doppler | Amplitude
Doppler
(Doppler
Tissue
Imaging) | Other
(specify)
Harmonic
Imaging |
|------------------------|---|---|-----|------------------|--------------------------------------------------------|-------------------------------------------|
| | | | | | | |
| Intraoperative-Cardiac | • | • | • | • | • | • |
| Cardiac (Adult) | • | • | • | • | • | • |
| Cardiac (Pediatric) | • | • | • | • | • | • |
| Transesophageal | • | • | • | • | • | • |

Additional Comments: Pediatric studies are dependent upon patient size. The Ecton Lynx does not provide Combined Modes (where more than one scanning mode is active simultaneously. )

New Submission: All Indications New

4.3 p 5

Prescription Use (Per 21 CFR 801.109)

Concurrence of CDRH, Office of Device Evaluation (ODE)

David H. Segner

(Division Sign-Off) (Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
Division of Reproductive, Abdominal, ENT, Division of Radiological Devices 510(k) Number